Synedgen to Partner with the NIH for Radiation Countermeasures Product…

Synedgen Active Agent SY303A will undergo Further Non-Clinical Efficacy Testing at the Armed Forces Radiobiology Research Institute (AFRRI), in Bethesda, Maryland

(PRWeb November 14, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!